<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Bauckneht M</submitter><funding>Associazione Italiana per la Ricerca sul Cancro</funding><funding>Ministero della Salute</funding><pagination>3</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9811737</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>21(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Positron Emission Tomography (PET) imaging with Prostate-Specific Membrane Antigen (PSMA) and Fluorodeoxyglucose (FDG) represent promising biomarkers for risk-stratification of Prostate Cancer (PCa). We verified whether the expression of genes encoding for PSMA and enzymes regulating FDG cellular uptake are independent and additive prognosticators in PCa.&lt;h4>Methods&lt;/h4>mRNA expression of genes involved in glucose metabolism and PSMA regulation obtained from primary PCa specimens were retrieved from open-source databases and analyzed using an integrative bioinformatics approach. Machine Learning (ML) techniques were used to create predictive Progression-Free Survival (PFS) models. Cellular models of primary PCa with different aggressiveness were used to compare [18F]F-PS</pubmed_abstract><journal>Journal of translational medicine</journal><pubmed_title>Gene's expression underpinning the divergent predictive value of [18F]F-fluorodeoxyglucose and prostate-specific membrane antigen positron emission tomography in primary prostate cancer: a bioinformatic and experimental study.</pubmed_title><pmcid>PMC9811737</pmcid><funding_grant_id>IG 23201</funding_grant_id><pubmed_authors>Morbelli S</pubmed_authors><pubmed_authors>Chiola S</pubmed_authors><pubmed_authors>Piana M</pubmed_authors><pubmed_authors>Riondato M</pubmed_authors><pubmed_authors>Barboro P</pubmed_authors><pubmed_authors>Miceli A</pubmed_authors><pubmed_authors>Cossu V</pubmed_authors><pubmed_authors>Chiesa S</pubmed_authors><pubmed_authors>D'Amico F</pubmed_authors><pubmed_authors>Fornarini G</pubmed_authors><pubmed_authors>Sambuceti G</pubmed_authors><pubmed_authors>Vitale F</pubmed_authors><pubmed_authors>Carta S</pubmed_authors><pubmed_authors>Bruno S</pubmed_authors><pubmed_authors>Terrone C</pubmed_authors><pubmed_authors>Marini C</pubmed_authors><pubmed_authors>Orengo AM</pubmed_authors><pubmed_authors>Campi C</pubmed_authors><pubmed_authors>Signori A</pubmed_authors><pubmed_authors>Bauckneht M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Gene's expression underpinning the divergent predictive value of [18F]F-fluorodeoxyglucose and prostate-specific membrane antigen positron emission tomography in primary prostate cancer: a bioinformatic and experimental study.</name><description>&lt;h4>Background&lt;/h4>Positron Emission Tomography (PET) imaging with Prostate-Specific Membrane Antigen (PSMA) and Fluorodeoxyglucose (FDG) represent promising biomarkers for risk-stratification of Prostate Cancer (PCa). We verified whether the expression of genes encoding for PSMA and enzymes regulating FDG cellular uptake are independent and additive prognosticators in PCa.&lt;h4>Methods&lt;/h4>mRNA expression of genes involved in glucose metabolism and PSMA regulation obtained from primary PCa specimens were retrieved from open-source databases and analyzed using an integrative bioinformatics approach. Machine Learning (ML) techniques were used to create predictive Progression-Free Survival (PFS) models. Cellular models of primary PCa with different aggressiveness were used to compare [18F]F-PS</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jan</publication><modification>2025-04-19T09:21:53.495Z</modification><creation>2025-02-19T03:31:28.479Z</creation></dates><accession>S-EPMC9811737</accession><cross_references><pubmed>36600265</pubmed><doi>10.1186/s12967-022-03846-1</doi></cross_references></HashMap>